Showing results (41-50 of 211) with videos related to
Sort By:
Pageof 22
Pharmacogenomics|January 23, 2016
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclinesDaniel L Hertz, Megan V Caram, Kelley M Kidwell, et al.Pharmacogenetics and Genomics|May 27, 2025
Pharmacogenetic association of CYP enzymes with therapeutic propofol doses during mechanical ventilationChanel Hsiang, Faisal Shakeel, Nicholas Farina, et al.Clinical and Translational Science|November 14, 2025
Pharmacokinetic-Pharmacodynamic Model of Paclitaxel-Induced Peripheral NeuropathyYuchen Sun, Manjunath P Pai, N Lynn Henry, et al.American Journal of Cancer Research|December 2, 2016
Vincristine-induced peripheral neuropathy in pediatric cancer patientsErika Mora, Ellen M Lavoie Smith, Clare Donohoe, et al.Pharmacogenetics and Genomics|January 20, 2025
Pharmacogenetic associations of GATA4 and KCNQ1 with ibrutinib cardiovascular toxicityKelly I Nugent, Lyucheng Huang, Jai N Patel, et al.Hormones & Cancer|March 13, 2016
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate CancerCameron P Capper, James M Rae, Richard J AuchusBritish Journal of Clinical Pharmacology|February 10, 2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.Physiological Genomics|August 21, 2016
ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumorsDaniel L Hertz, N Lynn Henry, Kelley M Kidwell, et al.Toxicology|April 4, 2019
Implication of environmental estrogens on breast cancer treatment and progressionThomas L Gonzalez, James M Rae, Justin A ColacinoTransactions of the American Clinical and Climatological Association|July 4, 2008
An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor statusMarc E Lippman, James M Rae, Arul M ChinnaiyanPageof 22